About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 4NCT02511236

Addressing Racial/Ethnic Tobacco Health Disparities Via Group Intervention

The purpose of this study is to test the effects of a group smoking cessation program. The study will also examine individual differences in response to the intervention program.

Lead sponsor: University of Miami•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

University of Miami

Collaborators

H. Lee Moffitt Cancer Center and Research Institute
James and Esther King Biomedical Research Program

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Self-identify as African American/Black, Hispanic (any race), or White non-Hispanic
•Smoke at least 5 cigarettes/day or carbon monoxide (CO) reading of at least 8 ppm
•be over age 18
•speak/read English and/or Spanish

Exclusion Criteria

•Contraindications for transdermal nicotine patch therapy (TNP)
•Cognitive or mental health impairment that inhibits group treatment
•Currently being treated for smoking cessation, alcoholism, or illicit drug use
•Unable to attend sessions
•Indications that participant is not appropriate for the study (e.g., aggressive, intoxicated, disruptive, visibly ill)
•Does not self-identify as African American, Hispanic, or White (non-Hispanic)

Related studies

RECRUITINGPhase 4

Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care

NCT06598397 · Human Immunodeficiency Virus (HIV), Smoking Cessation

Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain

NCT07080788 · Smoking Cessation Intervention, Pain, and more

Effects of Smoking on Network Connectivity in Patients With Schizophrenia Symptoms in Scz Patients

NCT07441928 · Smoking Cessation, Schizophenia Disorder

Personalized Tobacco Treatment in Primary Care (MOTIVATE)

NCT05846841 · Physician's Role, Smoking Cessation, and more

Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors

NCT07210567 · Smoking Cessation

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 24, 2021Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment356

Start dateAug 2015

Last updatedJun 24, 2021

Condition

Smoking Cessation

Locations shown

University of Miami

Coral Gables, Florida

H Lee Moffitt Cancer Center

Tampa, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 24, 2021Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions